SMNH compounds (oral, norovirus infection) (Spring Bank Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameSMNH compounds (oral, norovirus infection) (Spring Bank Pharmaceuticals)

Drug Alias NameSMNH compounds (oral, viral infections) (Spring Bank Pharmaceuticals)nucleotide based program (oral, broad spectrum viral infections) (Spring Bank Pharmaceuticals)small molecule nucleic acid hybrids (oral, viral infections) (Spring Bank Pharmaceuticals)nucleotide based program (oral, influenza) (Spring Bank Pharmaceuticals)

ClassificationSmall molecules > Nucleosides and nucleotide derivtives

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsNorovirus InfectionsVirus Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSpring Bank Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSpring Bank Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsNorovirus InfectionsVirus Diseases

Other Information

ATC CodeN/A